Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2000
Business Overview: The Company operates in the nutritional supplement market through a direct sales model involving independent Distributors and Managers. Operations are segmented into Domestic (United States) and International (Latin America, Asia Pacific, and Other) regions.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Sales Revenue | $79,977 | $72,178 |
| Cost of Goods Sold | $14,365 | $12,857 |
| Volume Incentives | $36,567 | $33,123 |
| SG&A Expenses | $22,110 | $18,539 |
| Operating Income | $6,935 | $7,659 |
| Net Income | $4,496 | $4,990 |
| Diluted EPS | $0.26 | $0.28 |
| Cash from Operations | $10,028 | $13,554 |
| Cash & Equivalents (End) | $26,005 | $30,641 |
| Short-Term Debt | $864 | $1,018 |
Note: All dollar amounts in thousands, except per-share data.
Material Changes vs. Prior Period
- Revenue Growth: Sales revenue increased 10.8% to $80.0 million, driven by a 35% surge in international sales (notably South Korea, Mexico, Japan, and Brazil). Conversely, domestic sales declined 1% due to increased competition.
- Profitability Decline: Net income decreased 9.9% to $4.5 million. Operating income fell 9.5% to $6.9 million.
- Expense Increases: SG&A expenses rose 19.3% (to 27.6% of sales) due to international expansion costs ($2.2 million) and domestic marketing ($1.4 million). Volume incentives increased 10.4% but decreased slightly as a percentage of sales.
- Cash Flow: Net cash provided by operating activities decreased 26% to $10.0 million, primarily due to a $2.9 million increase in accounts receivable from promotional credit extensions to domestic distributors.
- Balance Sheet: Total assets grew to $118.3 million. Cash and cash equivalents increased $7.6 million quarter-over-quarter.
Outlook, Risks, and Management Commentary
- Guidance & Expectations: Management expects cost of goods sold and volume incentives to decrease slightly as a percentage of sales for the remainder of 2000. SG&A is also expected to decrease as a percentage of sales. A $14 million facility expansion project is underway, expected to take two years.
- Market Risks: The Company faces strong competition in the domestic nutritional supplement market. International growth is a key driver, with a focus on re-launching operations in Japan and expanding in South Korea and Brazil.
- Liquidity: The Company maintains no credit facility but believes internal funds are sufficient for working capital. A prolonged economic downturn could adversely affect long-term liquidity.
- Capital Allocation: The Company repurchased 36,000 shares of common stock for $341,000 during the quarter. A dividend of 3 1/3 cents per share was declared for payment in May 2000.
- Legal: The Company is a defendant in various incidental lawsuits; management believes these will not have a material effect on financial position.
Investor Verification Checklist
- International Sustainability: Verify the durability of the 35% international sales growth, particularly in new markets like Japan and Israel.
- Domestic Competition: Assess the impact of "increased product and price competition" on future domestic distributor retention and sales volume.
- Receivables Quality: Monitor the $2.9 million increase in accounts receivable resulting from promotional credit extensions to ensure collectability.
- Expense Ratios: Track whether SG&A expenses stabilize as a percentage of sales following the heavy investment in international expansion.
- Capital Expenditures: Confirm the timeline and cost adherence of the $14 million facility expansion project.